» Articles » PMID: 27478478

α-Mangostin Induces Apoptosis and Cell Cycle Arrest in Oral Squamous Cell Carcinoma Cell

Overview
Date 2016 Aug 2
PMID 27478478
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Mangosteen has long been used as a traditional medicine and is known to have antibacterial, antioxidant, and anticancer effects. Although the effects of α-mangostin, a natural compound extracted from the pericarp of mangosteen, have been investigated in many studies, there is limited data on the effects of the compound in human oral squamous cell carcinoma (OSCC). In this study, α-mangostin was assessed as a potential anticancer agent against human OSCC cells. α-Mangostin inhibited cell proliferation and induced cell death in OSCC cells in a dose- and time-dependent manner with little to no effect on normal human PDLF cells. α-Mangostin treatment clearly showed apoptotic evidences such as nuclear fragmentation and accumulation of annexin V and PI-positive cells on OSCC cells. α-Mangostin treatment also caused the collapse of mitochondrial membrane potential and the translocation of cytochrome c from the mitochondria into the cytosol. The expressions of the mitochondria-related proteins were activated by α-mangostin. Treatment with α-mangostin also induced G1 phase arrest and downregulated cell cycle-related proteins (CDK/cyclin). Hence, α-mangostin specifically induces cell death and inhibits proliferation in OSCC cells via the intrinsic apoptosis pathway and cell cycle arrest at the G1 phase, suggesting that α-mangostin may be an effective agent for the treatment of OSCC.

Citing Articles

α-Mangostin: A Xanthone Derivative in Mangosteen with Potent Anti-Cancer Properties.

Majdalawieh A, Terro T, Ahari S, Abu-Yousef I Biomolecules. 2024; 14(11).

PMID: 39595559 PMC: 11591772. DOI: 10.3390/biom14111382.


A novel α-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms.

Ge R, Zhao H, Tang Q, Chandarajoti K, Bai H, Wang X Microbiol Spectr. 2024; :e0163124.

PMID: 39508612 PMC: 11619392. DOI: 10.1128/spectrum.01631-24.


Formulation of 1% α-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma.

Nittayananta W, Srichana T, Chuerduangphui J, Hitakomate E, Netsomboon K BMC Complement Med Ther. 2024; 24(1):276.

PMID: 39033112 PMC: 11264970. DOI: 10.1186/s12906-024-04450-0.


Newly designed nanoparticle-drug delivery systems against infection: a systematic review.

Kamarehei F, Saleh G, Hemmati J, Gohari S Int J Clin Exp Pathol. 2024; 17(4):96-107.

PMID: 38716352 PMC: 11070434. DOI: 10.62347/BVWH1940.


α-Mangostin Inhibits the Activation of Myofibroblasts via Downregulation of Linc-ROR-Mediated TGFB1/Smad Signaling.

Lee Y, Hsieh P, Chao S, Liao Y, Liu C, Yu C Nutrients. 2023; 15(6).

PMID: 36986051 PMC: 10051815. DOI: 10.3390/nu15061321.


References
1.
Pitts T, Davis S, Eckhardt S, Bradshaw-Pierce E . Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors. Pharmacol Ther. 2013; 142(2):258-69. DOI: 10.1016/j.pharmthera.2013.12.010. View

2.
Sato A, Fujiwara H, Oku H, Ishiguro K, Ohizumi Y . Alpha-mangostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells. J Pharmacol Sci. 2004; 95(1):33-40. DOI: 10.1254/jphs.95.33. View

3.
Kurose H, Shibata M, Iinuma M, Otsuki Y . Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-mangostin extracted from mangosteen pericarp. J Biomed Biotechnol. 2012; 2012:672428. PMC: 3332218. DOI: 10.1155/2012/672428. View

4.
Brinkmann K, Kashkar H . Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?. Cell Death Dis. 2014; 5:e1098. PMC: 3973243. DOI: 10.1038/cddis.2014.61. View

5.
Cicenas J, Kalyan K, Sorokinas A, Jatulyte A, Valiunas D, Kaupinis A . Highlights of the Latest Advances in Research on CDK Inhibitors. Cancers (Basel). 2014; 6(4):2224-42. PMC: 4276963. DOI: 10.3390/cancers6042224. View